Matthew Hawryluk - 07 Jan 2021 Form 4 Insider Report for Gritstone bio, Inc.

Role: Executive Vice President and Chief Business Officer
Signature: /s/ Rahsaan Thompson, Attorney-in-Fact for Matthew Hawryluk
Issuer symbol: N/A
Transactions as of: 07 Jan 2021
Net transactions value: $0
Form type: 4
Filing time: 19 Nov 2021, 15:45:16 UTC
Next filing: 20 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRTS	Common Stock	Award	$0	+19,600	+426%	$0.000000	24,198	07 Jan 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") which vest in two equal annual installments over a two year period measured from the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2	Includes 4,598 shares of common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c) and 19,600 RSUs which vest over time measured from the grant date.

Remarks:

Executive Vice President and Chief Business Officer